When Athletes Ask About Chronic Traumatic Encephalopathy.
10 affiliations
- 1Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA.
- 2NYU Langone Concussion Center, NYU Langone Health, 240 East 38th Street, 17th Floor, New York, NY, 10016, USA.
- 3Department of Rehabilitation Medicine, NYU Grossman School of Medicine, New York, NY, USA.
- 4Brain Injury Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 5Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 6Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 7Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 8NYU Langone Concussion Center, NYU Langone Health, 240 East 38th Street, 17th Floor, New York, NY, 10016, USA. [email protected].
- 9Department of Rehabilitation Medicine, NYU Grossman School of Medicine, New York, NY, USA. [email protected].
- 10Institute for Translational Neuroscience, NYU Grossman School of Medicine, New York, NY, USA. [email protected].
Abstract
Athletes exposed to repetitive head impacts (RHI) may seek clinical evaluation because of concerns about chronic traumatic encephalopathy (CTE), a neuropathologically defined disease that cannot currently be diagnosed during life. As public awareness of CTE has expanded, clinicians face challenges communicating diagnostic uncertainty, interpreting non-specific symptoms, and addressing concerns about future neurological health. This Current Opinion examines the widening gap between public expectations and scientific capability and considers its implications for athlete-centered care. We discuss how clinicians can acknowledge uncertainty without dismissing patients' concerns, identify potentially treatable contributors to symptoms without prematurely attributing them to neurodegenerative disease, and use shared decision-making to guide individualized evaluation and management. We also consider how concerns about CTE may influence decisions about continued participation and return-to-sport among current athletes. Meeting these challenges requires coordinated interdisciplinary care, evidence-based communication, and clinical approaches that prioritize meaningful intervention even when diagnostic certainty remains unavailable.
Related
- Fluid Biomarkers for the Antemortem Detection of Chronic Traumatic Encephalopathy: A Critical Review
- Chronic traumatic encephalopathy in a neuropathologically confirmed Creutzfeldt–Jakob disease cohort
- General semantic, personal semantic and episodic details when thinking about the past and the future in moderate-to-severe traumatic brain injury
- Bias-Adjusted Prevalence of Chronic Traumatic Encephalopathy Among Deceased National Football League Players
- Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21
BibTeX
@article{datta2026when,
title = {{When Athletes Ask About Chronic Traumatic Encephalopathy.}},
author = {Shae Datta and Brian S Im and Geraldine Pagnotta and Mara Sproul and Rebecca D Folkerth and Enna Selmanovic and Hector Arciniega},
journal = {Sports medicine - open},
year = {2026},
month = oct,
doi = {10.1186/s40798-026-01138-2},
url = {https://europepmc.org/article/MED/42963510},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - When Athletes Ask About Chronic Traumatic Encephalopathy.
AU - Shae Datta
AU - Brian S Im
AU - Geraldine Pagnotta
AU - Mara Sproul
AU - Rebecca D Folkerth
AU - Enna Selmanovic
AU - Hector Arciniega
PY - 2026
DA - 2026/10/30
JO - Sports medicine - open
DO - 10.1186/s40798-026-01138-2
UR - https://europepmc.org/article/MED/42963510
AB - Athletes exposed to repetitive head impacts (RHI) may seek clinical evaluation because of concerns about chronic traumatic encephalopathy (CTE), a neuropathologically defined disease that cannot currently be diagnosed during life. As public awareness of CTE has expanded, clinicians face challenges communicating diagnostic uncertainty, interpreting non-specific symptoms, and addressing concerns about future neurological health. This Current Opinion examines the widening gap between public expectations and scientific capability and considers its implications for athlete-centered care. We discuss how clinicians can acknowledge uncertainty without dismissing patients' concerns, identify potentially treatable contributors to symptoms without prematurely attributing them to neurodegenerative disease, and use shared decision-making to guide individualized evaluation and management. We also consider how concerns about CTE may influence decisions about continued participation and return-to-sport among current athletes. Meeting these challenges requires coordinated interdisciplinary care, evidence-based communication, and clinical approaches that prioritize meaningful intervention even when diagnostic certainty remains unavailable.
SN - 2199-1170
SN - 2198-9761
ER -